Clinical Trials Logo

Macula Edema clinical trials

View clinical trials related to Macula Edema.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05385562 Completed - Macula Edema Clinical Trials

Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

Start date: January 2, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to compare formulated Posterior Subtenon Triamcinolone acetonide (PSTA) injection versus Posterior Subtenon Triamcinolone acetonide alone in the management of macular edema secondary to non-ischemic retinal vein occlusions, either central or branch.

NCT ID: NCT04703231 Completed - Macula Edema Clinical Trials

Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause

Start date: September 1, 2020
Phase:
Study type: Observational

It is aimed to compare the ocular findings in patients with natural and surgical menopause.

NCT ID: NCT04359771 Completed - Clinical trials for Diabetic Retinopathy

Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema

Start date: January 22, 2018
Phase: Phase 4
Study type: Interventional

Anti-vascular endothelial growth factor (VEGF) therapy is currently the mainstay of treatment for diabetic macular edema (DME). One of the main obstacles of anti-VEGF therapy is the need of repeated injections, which carries both economic and compliance problems to the patients.there is a growing evidence that recognises the effectiveness of the use of micropulse laser (MPL) in treatment of DME. with MPL, it is possible to deliver a subthreshold laser that is above the threshold of biochemical effect but below the threshold of a visible, destructive lesion thereby preventing collateral damage.The MPL technique is available at near - infrared 810 nm diode laser (diode MPL) and at 577 nm (yellow MPL). The current study was conducted in order to compare the efficacy of both MPL techniques in the treatment of center involving DME.

NCT ID: NCT03363295 Completed - Cataract Clinical Trials

Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis

Start date: July 1, 2017
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the macular and choroidal thickness of patients submitted to intracameral moxifloxacin during the phacoemulsification surgery for endophthalmitis prophylaxis. The investigators propose a randomized clinical trial double-blind. The patients will be divided into two groups: one will receive intracameral moxifloxacin injection during phacoemulsification surgery and the other won't. Both Spectral Domain - Optical Coherence Tomography (SD-OCT) and Enhanced Depth Imaging - Optical Coherence Tomography (EDI-OCT) will be performed for each patient pre-operatively and on the 30th and 60th postoperative days. After collecting, the data will be compared to evaluate if there was any difference in the macular thickness and choroidal thickness between the two groups.

NCT ID: NCT03321253 Completed - Retinal Detachment Clinical Trials

Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification

Start date: October 23, 2015
Phase: N/A
Study type: Interventional

It has been hypothesized that potential effects of laser Nd: YAG laser posterior capsulotomy may affect macular pigment as well as choroidal thickness, macular thickness and anterior chamber parameters, so it was aimed to investigate possible effects of Nd: YAG laser posterior capsulotomy on macular pigment optical density, choroidal thickness, macular thickness and anterior chamber parameters in cases with posterior capsule opacification in this study.

NCT ID: NCT03093701 Completed - Clinical trials for Retinal Vein Occlusion

TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Start date: April 1, 2017
Phase: Phase 2
Study type: Interventional

Randomized, double-masked trial designed to investigate the use of TLC399 (ProDex) in subjects with macular edema due to CRVO or BRVO.